Sigma Healthcare Stock

Sigma Healthcare Equity

The The Equity of Sigma Healthcare (SIG.AX) as of Aug 12, 2026 is 4.67 B AUD. In the previous year, The Equity was 837.86 M AUD — a change of 457.44% (higher).

Equity

4.67 BAUD

YoY

457.44%

Last updated:

In 2026, Sigma Healthcare's equity was 4.67 B AUD, a 457.44% increase from the 837.86 M AUD equity in the previous year.

Access this data via the Eulerpool API

Sigma Healthcare Stock analysis

What does Sigma Healthcare do? Sigma Healthcare Ltd is an Australian company that has been operating in the healthcare industry for over 100 years. Founded in 1911 as a local pharmacy in Melbourne, the company has since become a leading provider of pharmaceutical services in Australia. The company's core business is the delivery of pharmacy products and services to pharmacies and medical practices across Australia. Sigma Healthcare Ltd supplies over 4,000 independent retailers as well as numerous large chains and department store pharmacies. Sigma Healthcare Ltd also offers various healthcare services, such as consulting, training, and support in medication delivery. Divided into different divisions, Sigma Healthcare Ltd offers a wide portfolio of products. In the pharmaceutical products division, the company distributes national and international medications, both prescription and over-the-counter. Additionally, health and personal care products such as medical devices, supplements, vitamins, and minerals are available. The general products division offers a variety of non-food products, such as personal care products, wellness products, hygiene products, cleaning agents, cosmetics, and household products. Another important division is the pharmacy management system, which supports pharmacies in managing their business and billing processes. The system complements the existing offering with additional features, such as inventory management, prescription processing, accounting, and customer loyalty. Innovation plays a central role at Sigma Healthcare Ltd. The company invests significant resources in researching and developing new products and services to continuously improve the customer experience and meet the ever-growing demands of the industry. The company benefits from close relationships with leading manufacturers and international organizations. Partnerships are another crucial aspect of Sigma Healthcare Ltd's business model. The company works closely with manufacturers, retailers, pharmacists, and other partners to jointly create innovative solutions and products to enhance the customer experience. In recent years, Sigma Healthcare Ltd has also pursued a significant growth strategy, such as acquiring companies that complement its existing portfolio. This includes the acquisition of API in 2020 and Discount Drug Stores in 2018, which have greatly expanded the offerings of Sigma Healthcare Ltd. Overall, Sigma Healthcare Ltd is an important company in the Australian healthcare industry. With a wide range of products and services, a strong culture of innovation, and significant partnerships with industry players, the company will continue to establish itself as a key player in healthcare and continuously improve the customer experience. Sigma Healthcare is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Sigma Healthcare's Equity

Sigma Healthcare's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sigma Healthcare's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sigma Healthcare's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sigma Healthcare's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sigma Healthcare’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sigma Healthcare stock

The Equity of Sigma Healthcare is 4.67 B AUD in 2026.

The Equity of Sigma Healthcare changed from 837.86 M AUD to 4.67 B AUD, representing a 457.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Sigma Healthcare since 2006 – with annual values, charts, and detailed analysis.

The Equity's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Sigma Healthcare historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Sigma Healthcare

All Key Metrics — Sigma Healthcare